Compare CBU & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBU | HAE |
|---|---|---|
| Founded | 1866 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 1994 | 1996 |
| Metric | CBU | HAE |
|---|---|---|
| Price | $64.82 | $77.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $66.67 | ★ $84.13 |
| AVG Volume (30 Days) | 214.6K | ★ 887.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | ★ 15.41 | N/A |
| EPS | 1.08 | ★ 2.05 |
| Revenue | $818,007,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $13.46 | N/A |
| Revenue Next Year | $7.75 | $5.23 |
| P/E Ratio | $59.17 | ★ $36.53 |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $51.12 | $47.32 |
| 52 Week High | $67.50 | $87.32 |
| Indicator | CBU | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 80.38 |
| Support Level | $60.80 | $48.98 |
| Resistance Level | $64.83 | $86.72 |
| Average True Range (ATR) | 1.34 | 3.03 |
| MACD | 0.05 | 1.35 |
| Stochastic Oscillator | 72.41 | 89.26 |
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional, and governmental customers. The Company also offers comprehensive financial planning, trust administration, and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services, and Wealth Management Services. The group generates the majority of its revenue from the Banking and Corporate segment.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.